0
0
2/13/23 at 5:01am
Organization
The Globe And Mail
Author
Carly Weeks
42 words
0
Comments
New study suggests that higher-risk individuals will continue to benefit from taking Paxlovid after testing positive for COVID-19 during the Omicron era
You are the first to view
https://www.theglobeandmail.com/canada/article-a-new-canadian-study-found-that-high-risk-covid-19-patients-treated/
Create an account
or login to join the discussion